Andrew Almonte

Australian National University

H-index: 3

Oceania-Australia

About Andrew Almonte

Andrew Almonte, With an exceptional h-index of 3 and a recent h-index of 3 (since 2020), a distinguished researcher at Australian National University, specializes in the field of Immunotherapy, gut microbiome, cancer immunology.

His recent articles reflect a diverse array of research interests and contributions to the field:

Response to COVID‐19 vaccination in patients on cancer therapy: Analysis in a SARS‐CoV‐2‐naïve population

Early T Cell Infiltration Correlates with Anti-CTLA4 Treatment Response in Murine Cancer Models

Bacteria-based cancer immunotherapy: A re-emerging strategy with contemporary implications

Gut microbiome-depleting antibiotic regimens are not tolerated by all mouse strains: learn from (our) bitter experience

COVID-19 VACCINE RESPONSE IN PATIENTS ON CANCER THERAPY-EVIDENCE FROM AUSTRALIAN DATA

How does the gut microbiome influence immune checkpoint blockade therapy?

Simple and effective bacterial-based intratumoral cancer immunotherapy

Andrew Almonte Information

University	Australian National University
Position	___
Citations(all)	44
Citations(since 2020)	44
Cited By	6
hIndex(all)	3
hIndex(since 2020)	3
i10Index(all)	2
i10Index(since 2020)	2
Email	Access Email
University Profile Page	Australian National University
Google Scholar	View Google Scholar Profile